NOVA.DU Novo Nordisk A/S

- EUR
Market cap
-
P/E
10.2x
P/B
5.32x
ROE
-
Dividend yield
1.17%
Fundamental score
-

Is NOVA.DU undervalued?

Graham number

The Graham number of Novo Nordisk A/S cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Novo Nordisk A/S fundamental analysis

No fundamental analysis for Novo Nordisk A/S yet.

Novo Nordisk A/S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.